Retrospective review of Her2 positive metastatic breast cancer patients who received Pertuzumab and Herceptin as a first line therapy at KFSH&RC (single institute experience) from 2013 to 2016

Saved in:
Bibliographic Details
Published in:Breast (Edinburgh) 2019-03, Vol.44, p.S64
Main Authors: Suleman, K., Mushtaq, A., Haque, E., Badran, A., Ajarim, D., Tweigeri, T., Elashwah, A., Shahin, A., Khan, K., Alsayed, A.
Format: Article
Language:eng ; jpn
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0960-9776
DOI:10.1016/S0960-9776(19)30245-0